452 related articles for article (PubMed ID: 8734357)
1. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
2. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
3. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
4. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.
Dionne S; Hiscott J; D'Agata I; Duhaime A; Seidman EG
Dig Dis Sci; 1997 Jul; 42(7):1557-66. PubMed ID: 9246063
[TBL] [Abstract][Full Text] [Related]
5. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Kenney JS; Baumann R; Poindron P; Duclos B
Gut; 1996 Nov; 39(5):684-9. PubMed ID: 9026483
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
7. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.
Woywodt A; Neustock P; Kruse A; Schwarting K; Ludwig D; Stange EF; Kirchner H
Eur Cytokine Netw; 1994; 5(4):387-95. PubMed ID: 7841354
[TBL] [Abstract][Full Text] [Related]
8. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.
Woywodt A; Ludwig D; Neustock P; Kruse A; Schwarting K; Jantschek G; Kirchner H; Stange EF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):267-76. PubMed ID: 10333199
[TBL] [Abstract][Full Text] [Related]
9. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
Ishiguro Y
J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
[TBL] [Abstract][Full Text] [Related]
11. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
[TBL] [Abstract][Full Text] [Related]
12. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
MacDermott RP; Schreiber S; Nash GS; Koopman WJ
Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease.
Sakai T; Kusugami K; Nishimura H; Ando T; Yamaguchi T; Ohsuga M; Ina K; Enomoto A; Kimura Y; Yoshikai Y
Gastroenterology; 1998 Jun; 114(6):1237-43. PubMed ID: 9609761
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
15. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.
Noguchi M; Hiwatashi N; Liu Z; Toyota T
Gut; 1998 Aug; 43(2):203-9. PubMed ID: 10189845
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.
Gibson P; Rosella O
Gut; 1995 Oct; 37(4):536-43. PubMed ID: 7489942
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
20. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]